Zhejiang Ausun Pharmaceutical Co.Ltd(603229) : reply to the Zhejiang Ausun Pharmaceutical Co.Ltd(603229) inquiry on matters related to abnormal fluctuations in stock trading Zhejiang Ausun Pharmaceutical Co.Ltd(603229) : we have received the Zhejiang Ausun Pharmaceutical Co.Ltd(603229) inquiry on matters related to abnormal fluctuations in stock trading from your company. After careful self-examination and verification, my reply on relevant matters is as follows: as the controlling shareholder and actual controller of Zhejiang Ausun Pharmaceutical Co.Ltd(603229) (hereinafter referred to as the “listed company”), up to now, there are no major matters affecting the abnormal fluctuation of the stock price of the listed company, and there are no other major matters that should be disclosed but not disclosed, including but not limited to major asset restructuring, issuance of shares Major issues such as the acquisition of listed companies, debt restructuring, business restructuring, asset divestiture and asset injection. We hereby reply. (there is no text below, and the signature page is attached)
© China Stock Market News